EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CALM1 , CALM2 , and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy

Steffan Noe Niikanoff Christiansen iD, Stine Bøttcher Jacobsen iD, Jeppe Dyrberg Andersen iD, Ya Cui iD, Wei Li iD, Christian Staehr iD, Mikkel Meyer Andersen iD, Lia Crotti iD, Carla Spazzolini iD, Peter J Schwartz iD, Mette Nyegaard iD, Michael Toft Overgaard iD

Europace · 30.03.2026 · 28 (4)

DOI: 10.1093/europace/euag052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, online erschienen am 18.03.2026. Verfasst von Steffan Noe Niikanoff Christiansen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Science and Technology, Aalborg University, Selma Lagerløfs Vej 249, 9260 Gistrup, Aalborg, Denmark. Hauptthemen laut MEDLINE: Calmodulin, Mutation, Missense, Protein Biosynthesis, Arrhythmias, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Danish Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Missense variants in the CALM1, CALM2, and CALM3 genes cause calmodulinopathy, which is characterized by ventricular arrhythmias and sudden cardiac death. Although the three genes encode an identical protein, their individual roles and gene-specific clinical implications remain poorly understood. We aimed to determine the relative contribution from each of the genes to the total calmodulin amount and assess the consequence of missense mutations on the severity of calmodulinopathy. Methods and results Using data from the Genotype-Tissue Expression (GTEx) project, we show that CALM2 constituted a higher percentage of the calmodulin-coding mRNA (41.9%) compared with CALM1 (36.8%) and CALM3 (21.3%) (P < 2 × 10−16). Paired RNA sequencing and ribosome profiling data from the left ventricle was used to demonstrate that the translation into calmodulin protein was significantly different among CALM1 (44.8%) and CALM2 (44.2%), and CALM3 (11.0%) (P < 2 × 10−16). The observed-to-expected ratio for the number of missense variants in the Genome Aggregation Database (gnomAD) was 0.29 (90% CI, 0.23–0.36) in CALM3, 0.20 (90% CI, 0.15–0.27) in CALM2, and 0.11 in CALM1 (90% CI, 0.07–0.17). In the International Calmodulinopathy Registry, a different percentage of carriers experiencing cardiac events was observed among those with missense variants in CALM1 (46/52, 89%), CALM2 (37/53, 70%), and CALM3 (20/35, 57%) (P = 0.004).

Conclusion

Compared with CALM1 and CALM2, CALM3 is under less negative selection and missense variant carriers are less prone to cardiac events. We suggest this is partially due to CALM3 accounting for only 11% of the calmodulin protein produced in the ventricles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalmodulinMutation, MissenseProtein BiosynthesisArrhythmias, CardiacHumansSeverity of Illness IndexGenetic Predisposition to DiseasePhenotypeRibosome ProfilingRNA, MessengerDeath, Sudden, Cardiac

Stichwörter der Autor:innen

CALM1CALM2CALM3CalmodulinCalmodulinopathyGene expressionTranslational efficiencyUntranslated regions

Substanzen

CalmodulinCALM1 protein, humanCALM2 protein, humanRNA, Messenger

Autor:innen und Institutionen

  • Department of Health Science and Technology, Aalborg University, Selma Lagerløfs Vej 249, 9260 Gistrup, Aalborg, Denmark.
  • Department of Forensic Medicine, University of Copenhagen, Frederik V's Vej 11, 2100 Copenhagen, Denmark.
  • Division of Computational Biomedicine, Department of Biological Chemistry, University of California, Irvine, CA, USA.
  • Department of Biomedicine, Health, Aarhus University, Aarhus, Denmark.
  • Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark.

ORCID-Profile: Steffan Noe Niikanoff Christiansen, Stine Bøttcher Jacobsen, Jeppe Dyrberg Andersen, Ya Cui, Wei Li, Christian Staehr, Mikkel Meyer Andersen, Lia Crotti, Carla Spazzolini, Peter J Schwartz, Mette Nyegaard, Michael Toft Overgaard

Förderung

  • Novo Nordisk Foundation
  • Danish Heart Foundation

Zitieren

APA

Christiansen, S. N. N., Jacobsen, S. B., Andersen, J. D., Cui, Y., Li, W., Staehr, C., Andersen, M. M., Crotti, L., Spazzolini, C., Schwartz, P. J., Nyegaard, M., & Overgaard, M. T. (2026). CALM1 , CALM2 , and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy. Europace, 28(4). https://doi.org/10.1093/europace/euag052

Vancouver

Christiansen SNN, Jacobsen SB, Andersen JD, Cui Y, Li W, Staehr C, et al. CALM1 , CALM2 , and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy. Europace. 2026;28(4). doi:10.1093/europace/euag052

BibTeX
@article{Christiansen2026,
  author = {Christiansen, Steffan Noe Niikanoff and Jacobsen, Stine Bøttcher and Andersen, Jeppe Dyrberg and Cui, Ya and Li, Wei and Staehr, Christian and Andersen, Mikkel Meyer and Crotti, Lia and Spazzolini, Carla and Schwartz, Peter J and Nyegaard, Mette and Overgaard, Michael Toft},
  title = {CALM1 , CALM2 , and CALM3 expression and translation efficiency provide insight into the severity of calmodulinopathy},
  journal = {Europace},
  year = {2026},
  volume = {28},
  number = {4},
  doi = {10.1093/europace/euag052}
}
Kostenlos starten →